| Document Type
|
:
|
BL
|
| Record Number
|
:
|
995197
|
| Doc. No
|
:
|
b749567
|
| Title & Author
|
:
|
Initial guidance for an update of the National Vaccine Plan : : a letter report to the National Vaccine Program Office /\ Committee on the Review of Priorities in the National Vaccine Plan, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies.
|
| Publication Statement
|
:
|
Washington, D.C. :: National Academies Press,, 2008.
|
| Page. NO
|
:
|
1 online resource (x, 28 pages)
|
| ISBN
|
:
|
030912199X
|
|
|
:
|
: 1281726842
|
|
|
:
|
: 9780309121996
|
|
|
:
|
: 9781281726841
|
|
|
:
|
0309121981
|
|
|
:
|
9780309121989
|
| Notes
|
:
|
"This letter report contains the committee's initial guidance to the National Vaccine Program Office and its partners as they draft the update to the National Vaccine Plan."
|
| Bibliographies/Indexes
|
:
|
Includes bibliographical references.
|
| Contents
|
:
|
Background -- Features of the 1994 national vaccine plan -- The committee's approach to reviewing the plan -- Changes since 1994 -- Progress since 1994 -- Guidance for developing a new national vaccine plan -- Process issues -- Content areas -- Concluding remarks -- References -- Statement of task -- Meeting one agenda -- 1994 national vaccine plan goals, objectives, and anticipated outcomes.
|
| Abstract
|
:
|
This book is the Institute of Medicine's response to the first part of the statement of task asking for a review of the 1994 National Vaccine Plan. The Committee on the Review of Priorities in the National Vaccine Plan reviewed the goals, objectives, strategies, and anticipated outcomes presented in the plan; their findings are contained in this book. In the first section of the book, the committee examines what has changed in the broader social, policy, and economic context of vaccine development and immunization, and highlights several areas where noteworthy progress has been made, particularly by federal agencies. The committee acknowledges that progress in developing and delivering vaccines has benefited from essential contributions by other stakeholders, including researchers, manufacturers, state and local public health agencies, and health care providers. In the second section of the book, the committee uses what it learned from reviewing the 1994 plan and the process of preparing it to distill key elements. Based on these elements, the committee offers guidance to NVPO and its partners on developing the update to the national vaccine plan.
|
| Subject
|
:
|
National Vaccine Plan (U.S.)
|
|
|
:
|
National Vaccine Plan (U.S.)
|
| Subject
|
:
|
Communicable diseases-- United States-- Prevention.
|
| Subject
|
:
|
Immunization-- United States.
|
| Subject
|
:
|
Vaccination-- United States.
|
| Subject
|
:
|
Communicable diseases-- Prevention.
|
| Subject
|
:
|
Immunization.
|
| Subject
|
:
|
MEDICAL-- Epidemiology.
|
| Subject
|
:
|
MEDICAL-- Health Risk Assessment.
|
| Subject
|
:
|
Vaccination.
|
| Subject
|
:
|
Immunization Programs-- organization administration-- United States.
|
| Subject
|
:
|
Immunization Programs-- United States, Guideline.
|
| Subject
|
:
|
Communicable Disease Control-- United States.
|
| Subject
|
:
|
Health Priorities-- United States, Guideline.
|
| Subject
|
:
|
Vaccines-- United States.
|
| Subject
|
:
|
United States.
|
| Dewey Classification
|
:
|
614.4/7
|
| LC Classification
|
:
|
RA638.I55 2008eb
|
| NLM classification
|
:
|
2008 M-543
|
|
|
:
|
WA 115I59i 2008
|
| Added Entry
|
:
|
Institute of Medicine (U.S.)., Committee on the Review of Priorities in the National Vaccine Plan.
|
| Parallel Title
|
:
|
Letter report to the National Vaccine Program Office
|